GreyBird Ventures
Overview
GreyBird Ventures is a venture capital firm that invests in companies developing products for precision medicine, with a focus on medical and diagnostic technology.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Atlas5D | Feb 2016 | Series A | Lead |
| Hummingbird Diagnostics GmbH | Jan 2016 | Seed | Lead |
| NeuroKaire | Dec 2024 | VC Round | Lead |
| JF Healthcare | Apr 2019 | Strategic | Lead |
| Angstrom Bio, Inc. | Jun 2021 | VC Round | Lead |
For institutional investors. Book with your work email.
Key People
Tom Miller
Founder and Managing Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is GreyBird Ventures based?
GreyBird Ventures is headquartered in Concord, Massachusetts, United States.
When was GreyBird Ventures founded?
GreyBird Ventures was founded in 2016.
How many portfolio companies does GreyBird Ventures have?
GreyBird Ventures has 7 portfolio companies in Caplight's dataset.
What are some companies in GreyBird Ventures's portfolio?
Portfolio companies visible on Caplight include Atlas5D, Hummingbird Diagnostics GmbH, NeuroKaire, JF Healthcare, Angstrom Bio, Inc..
What was GreyBird Ventures's most recent investment shown here?
GreyBird Ventures's most recent investment in this portfolio sample was in NeuroKaire in 2024.
What sectors does GreyBird Ventures focus on?
GreyBird Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure.
What company stages does GreyBird Ventures focus on?
Stage focus information for GreyBird Ventures is not publicly available.